HEIDI BEAVAN: Open Payments
NPI 1316311624 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,258 in 24 payments from 8 companies in 2025. Trend: 2023 $1,350 · 2024 $2,345 · 2025 $1,258
Food & beverage: $1,258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $407 |
| KYOWA KIRIN, INC. | 2 | $215 |
| Abbott Laboratories | 1 | $122 |
| Novo Nordisk Inc | 1 | $121 |
| Insulet Corporation | 1 | $117 |
| Biogen, Inc. | 1 | $95 |
| Neurelis, Inc. | 1 | $93 |
| Sumitomo Pharma America, Inc. | 1 | $89 |
Products named: BOTOX, FREESTYLE LIBRE 3, Wegovy, OMNIPOD, CRYSVITA, ZURZUVAE, VALTOCO, MYFEMBREE.
Industry payments across KY — which companies pay providers there.
